Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erector spinae plane block in minimally invasive direct coronary artery bypass surgery
2019-000596-16Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Ropivacaine erector spinae plane block with Placebo erector spinae plane block (2 arms). Primary endpoint: Cumulative 24-hour morphine consumption post-extubation. Started Mar 2019; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2019-000596-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000596-16.